Denali Therapeutics (NASDAQ:DNLI) Coverage Initiated by Analysts at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft started coverage on shares of Denali Therapeutics (NASDAQ:DNLI – Get Free Report) in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The firm set a “buy” rating and a $31.00 price target on the stock. Deutsche Bank Aktiengesellschaft’s price objective would indicate a potential upside of 48.90% from the […]
Deutsche Bank Aktiengesellschaft started coverage on shares of Denali Therapeutics (NASDAQ:DNLI – Get Free Report) in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The firm set a “buy” rating and a $31.00 price target on the stock. Deutsche Bank Aktiengesellschaft’s price objective would indicate a potential upside of 48.90% from the […]
